International Keratoconus Academy Symposium: What to expect
CEO and cofounder of the International Keratoconus Academy S. Barry Eiden, OD, FAAO, FSLS, sits down to discuss the inaugural symposium, which will be held April 22-23, 2023, in Scottsdale, Arizona.
International Keratoconus Academy continues to provide cutting-edge education
Over the years, IKA has become an invaluable resource for eye care professionals.
Role of Aceclidine in Presbyopia Treatment
Expert eye care specialists comment on the use of aceclidine as a selective miotic for the treatment of presbyopia.
Miotic Selectivity in the Management of Presbyopia
Andrew S. Morgenstern discusses the selectivity of miotic agents in isolating the pupil while limiting adverse events for the management of presbyopia.
Miotic Treatment Options for Presbyopia
Francis S. Mah, MD, reviews miotic agents that are available or under investigation for the treatment of presbyopia.
Targeting Pupil Size for Presbyopia Management
Andrew S. Morgenstern, OD, FAAO, FNAP, highlights the importance of reducing pupil size to a certain level to optimize near vision for patients with presbyopia.
Using Miotic Agents for the Management of Presbyopia
Expert eye care specialists discuss the role of miotic agents in targeting presbyopia in patients.
Woo U and IKA join forces for the Keratoconus Essentials Program
Stephanie Woo, OD, FAAO, FSLS, and S. Barry Eiden, OD, FAAO, discuss the Keratoconus Essentials Program, a joint effort between Woo University and the International Keratoconus Academy.
Impact of Presbyopia on Mechanism of Ocular Accommodation
Drs Andrew S. Morgenstern and Francis S. Mah provide insight on the functionality of ocular accommodation as an autofocus lens and how this is affected in patients with presbyopia.
Overview of Presbyopia
Francis S. Mah, MD, and Andrew S. Morgenstern, OD, FAAO, FNAP, review the impact of presbyopia on quality of life as well as current treatment options and unmet needs for disease management.
2 Clarke Drive Cranbury, NJ 08512